Alzheimer's Disease Research Center (ADRC), University of Washington

Welcome

The UW Alzheimer’s Disease Research Center (ADRC) is one of a nationwide network of 30 research resource centers funded by the National Institute on Aging. ADRCs are major sources of discovery into the nature of Alzheimer’s disease and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. The UW ADRC contributes to the development of shared resources that support dementia-relevant research, and coordinates research efforts with other NIH-funded programs and investigators. UW ADRC resources are designed to facilitate and empower related research efforts at UW.

The UW ADRC is closely affiliated with the UW Memory and Brain Wellness Center clinic and links the Seattle community with information and opportunities to participate in studies of Alzheimer’s disease and related disorders (Lewy Body dementia, and frontotemporal degeneration, and vascular dementia). Our busy outreach team is influential in promoting strengths-based reframing of Alzheimer’s disease and dementia-friendly communities, and they organize and promote educational public talks and events and research seminars. We support outreach and culturally adapted Alzheimer’s disease programs for Indigenous communities and clinics. Join us!

Director: Dr. Thomas J. Grabowski, MD
Program Manager: Annika Noreen, PhD, PMP

Announcements

February 6, 10am: ADRC Pilot Project Update

January 08, 2020 — Come and hear Dr. Robert J. Freishtat, MD, MPH present: Obesity and Dementia: MicroRNAs from Adipocyte-derived Small Extra Vesicles are Associated with Neurodegenerative Pathways. Location: Harborview Medical Center, Ninth and Jefferson Building NJB 1207 (12th Floor Conference Room).


February 3, 4pm: Toward Precision Medicine Seminar with Dr. Julie Saugstad, PhD

January 08, 2020 — We are excited to host Dr. Saugstad for her talk: MicroRNA Biomarkers for Alzheimer’s Disease: Performance in Mild Cognitive Impairment and Traumatic Brain Injury on Monday, February 3, 2020 4:00-5:00 pm. Harborview Medical Center's Ninth and Jefferson Building NJ1007 (10th floor conference room).


Kraemer Lab research on tau pathology published today in Science Translational Medicine.

December 18, 2019 — Researchers in Kraemer Lab discover the role of MSUT2 gene and binding protein in susceptibility to tau pathology, offering others a starting point for new therapeutics for Alzheimer's and FTD. Article and video available.


December 11: Allen Institute Distinguished Seminar Series: Carlos Brody,  Princeton University, presents “Collicular circuits for executive control.”

December 04, 2019 — Carlos Brody, Investigator of the Howard Hughes Medical Institute and Professor in Neuroscience at Princeton University, will explore decision-making processes and computational models of the superior colliculus. December 11, 10:30 AM - 11:30 AM. Location: Allen Institute. Learn more and register.

Upcoming Research Events

Loading...

Loading...